|
Vaccine Detail
rORFV-CSFV-E2 |
Vaccine Information |
- Vaccine Name: rORFV-CSFV-E2
- Target Pathogen: Classical swine fever virus
- Target Disease: Classical swine fever, hog cholera
- Vaccine Ontology ID: VO_0004768
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- E2
gene engineering:
- Type: Recombinant vector construction
- Description: Using the new recombinant parapoxvirus (PPV) Orf virus (ORFV) as a vaccine expressing the CSFV E. (Voigt et al., 2007).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: (Voigt et al., 2007) the recombinant parapoxvirus (PPV) Orf virus (ORFV) as a vaccine expressing the CSFV E2 glycoprotein to protect CSFV chellange.
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Pig Response
- Vaccination Protocol: Pigs were vaccinated with ORFV (Voigt et al., 2007).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: Pigs were challenged with CSFV (Voigt et al., 2007).
- Efficacy: Vector virus vaccinated swine were able to cope with the lymphocyte and in particular B-cell depression in peripheral blood after challenge showing no clinical signs and no viremia. Also, the vaccinated swine demonstrated that a single intra-muscular application confers solid protection (Voigt et al., 2007).
|
References |
Voigt et al., 2007: Voigt H, Merant C, Wienhold D, Braun A, Hutet E, Le Potier MF, Saalmüller A, Pfaff E, Büttner M. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2). Vaccine. 2007; 25(31); 5915-5926. [PubMed: 17600594].
|
|